Children’s Cancer Institute welcomes the Governor-General as Patron
July 28, 2014
Children’s Cancer Institute is extremely proud to announce that His Excellency General the Honourable Sir Peter Cosgrove AK MC (Retd), Governor-General of the Commonwealth of Australia, has become a Patron for our organisation.
Sir Peter was delighted to accept the role as Patron for Children’s Cancer Institute as he sees our work as complementary to his responsibilities as Governor-General and to themes of personal interest to him. When considering requests from groups inviting him to be Patron, the Governor-General focuses on organisations that have the broadest national significance and service community needs with active and inclusive programs.
“We are thrilled that the Governor-General has agreed to be a Patron for the Institute,” said Professor Michelle Haber AM, Executive Director, Children’s Cancer Institute. “To be formally associated with someone who plays such an important role in Australian national life is an honour.
“Sir Peter has been recognised for his leadership in rebuilding communities, which complements Children’s Cancer Institute’s own community, with the children, parents, researchers, clinicians and supporters across Australia who share our determination to stop this disease.
“Sir Peter’s dedication and support of Children’s Cancer Institute really highlights the importance of reducing the suffering that a diagnosis of childhood cancer brings to families throughout Australia. For us, it’s not a question of if we will cure childhood cancer, it’s when. And with such esteemed support, we know we will get the job done.”
About Children’s Cancer Institute
Originally founded by two fathers of children with cancer in 1976, Children’s Cancer Institute is the only independent medical research institute in Australia wholly dedicated to research into the causes, prevention and cure of childhood cancer. Forty years on, our vision remains unchanged – to save the lives of all children with cancer and to eliminate their suffering. The Institute has grown to now employ more than 220 researchers, operational staff and students, and has established a national and international reputation for scientific excellence.
Our focus is on translational research, and we have an integrated team of laboratory researchers and clinician scientists who work together in partnership to discover new treatments which can be progressed from the lab bench to the beds of children on wards in our hospitals as quickly as possible. These new treatments are specifically targeting childhood cancers, so we can develop safer and more effective drugs and drug combinations that will minimise side-effects and ultimately give children with cancer the best chance of a cure with the highest possible quality of life.
We are currently leading the establishment of the Zero Childhood Cancer national child cancer personalised medicine program for children with the most aggressive cancers, in partnership with the Sydney Children’s Hospitals Network. This program will revolutionise the way treatment decisions are made, with the aim of improving survivorship for those children at highest risk of treatment failure from their disease.